What is OnKure Therapeutics, Inc.'s interest income operating?

OnKure Therapeutics, Inc. (OKUR) reported interest income operating of $458K in Q1 2026.

How has OnKure Therapeutics, Inc.'s interest income operating changed year-over-year?

OnKure Therapeutics, Inc.'s interest income operating decreased by 57.4% year-over-year, from $1.08M to $458K.

What is the long-term trend for OnKure Therapeutics, Inc.'s interest income operating?

Over 2 years (2023 to 2025), OnKure Therapeutics, Inc.'s interest income operating has grown at a 45.6% compound annual growth rate (CAGR), from $1.62M to $3.44M.

OnKure Therapeutics, Inc. OKUR Interest Income Operating

Interest Income Operating at other companies

Drilling Tools InternationalDTI

$91K0.0%

Comstock Holding Companies, Inc.CHCI

$40K-38.5%

DiodesDIOD

$3.42M-19.7%

SB Financial GroupSBFG

$19.31M+11.1%

Lesaka Technologies, Inc.LSAK

$1.15M+78.9%

BlackSky TechnologyBKSY

$552K+34.0%

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Return on equity-42.7%—

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOperating.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s interest income operating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s interest income operating?: OnKure Therapeutics, Inc. (OKUR) reported interest income operating of $458K in Q1 2026.
How has OnKure Therapeutics, Inc.'s interest income operating changed year-over-year?: OnKure Therapeutics, Inc.'s interest income operating decreased by 57.4% year-over-year, from $1.08M to $458K.
What is the long-term trend for OnKure Therapeutics, Inc.'s interest income operating?: Over 2 years (2023 to 2025), OnKure Therapeutics, Inc.'s interest income operating has grown at a 45.6% compound annual growth rate (CAGR), from $1.62M to $3.44M.